AstraZeneca spins off autoimmune drugs into new biotech company

LONDON (Reuters) - AstraZeneca is spinning off six early-stage experimental drugs into a new $250 million standalone biotech company focused on severe autoimmune diseases.

Mississippi moves closer to banning abortions after 15 weeks

(Reuters) - Mississippi moved a step closer on Tuesday to passing the United States' most restrictive abortion law when a state Senate committee approved a bill banning most procedures after 15 weeks of gestation.

U.S. subpoenas Mallinckrodt for information on opioid painkillers

(Reuters) - Pharmaceutical company Mallinckrodt Plc on Tuesday said that it had received a grand jury subpoena from federal prosecutors in Florida seeking documents related to generic drugs it produces that contain the opioid painkiller oxymorphone.